Medikamente freisetzende Koronarstents und mit Medikamenten beschichtete Ballonkatheter (Q56638730)

1

0 references

B. Levenson

3

0 references

M. Joner

4

0 references

R. Zahn

5

0 references

V. Klauss

6

0 references

C. Naber

7

0 references

V. Schächinger

8

0 references

A. Elsässer

Transluminal dilatation of coronary-artery stenosis.

9

0 references

publication date

25 November 2011

0 references

published in

Der Kardiologe

0 references

volume

5

0 references

issue

6

0 references

page(s)

411-435

0 references

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary Artery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Physiological transport forces govern drug distribution for stent-based delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Cost-effectiveness of drug-eluting stents in patients at high or low risk of major cardiac events in the Basel Stent KostenEffektivitäts Trial (BASKET): an 18-month analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Cost-effectiveness of drug-eluting stents versus bare metal stents in clinical practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Drug-Eluting versus Bare-Metal Stents in Large Coronary Arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Efficacy and safety of zotarolimus-eluting and sirolimus-eluting coronary stents in routine clinical care (SORT OUT III): a randomised controlled superiority trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Increased rate of stent thrombosis with DES

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Five-year clinical and angiographic outcomes of a randomized comparison of sirolimus-eluting and paclitaxel-eluting stents: results of the Sirolimus-Eluting Versus Paclitaxel-Eluting Stents for Coronary Revascularization LATE trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Randomized, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for treatment of native coronary artery lesions: clinical and angiographic results of the ENDEAVOR II trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Comparison of zotarolimus-eluting and sirolimus-eluting stents in patients with native coronary artery disease: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Long-term clinical and economic analysis of the Endeavor zotarolimus-eluting stent versus the cypher sirolimus-eluting stent: 3-year results from the ENDEAVOR III trial (Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Co

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

A randomized comparison of the Endeavor zotarolimus-eluting stent versus the TAXUS paclitaxel-eluting stent in de novo native coronary lesions 12-month outcomes from the ENDEAVOR IV trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Improved late clinical safety with zotarolimus-eluting stents compared with paclitaxel-eluting stents in patients with de novo coronary lesions: 3-year follow-up from the ENDEAVOR IV (Randomized Comparison of Zotarolimus- and Paclitaxel-Eluting Sten

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Comparison of zotarolimus-eluting stents with sirolimus- and paclitaxel-eluting stents for coronary revascularization: the ZEST (comparison of the efficacy and safety of zotarolimus-eluting stent with sirolimus-eluting and paclitaxel-eluting stent f

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Comparison of zotarolimus-eluting and everolimus-eluting coronary stents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Unrestricted randomised use of two new generation drug-eluting coronary stents: 2-year patient-related versus stent-related outcomes from the RESOLUTE All Comers trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Clinical evaluation of the Resolute zotarolimus-eluting coronary stent system in the treatment of de novo lesions in native coronary arteries: the RESOLUTE US clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Randomized comparison of the Nobori Biolimus A9-eluting coronary stent with the Taxus Liberté paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries: the NOBORI 1 trial--Phase 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

The paclitaxel-eluting Coroflex Please stent study (PECOPS I): the 3-year clinical follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Durability of antirestenotic efficacy in drug-eluting stents with and without permanent polymer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents: a prospective, non-randomised multicentre trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Genous endothelial progenitor cell capturing stent vs. the Taxus Liberte stent in patients with de novo coronary lesions with a high-risk of coronary restenosis: a randomized, single-centre, pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Two year follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Outcomes and complications associated with off-label and untested use of drug-eluting stents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Clinical outcomes and stent thrombosis following off-label use of drug-eluting stents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Unanswered questions--drug-eluting stents and the risk of late thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Coronary stenting with the sirolimus-eluting stent in clinical practice: final results from the prospective multicenter German Cypher Stent Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Ostial and midshaft lesions vs. bifurcation lesions in 1111 patients with unprotected left main coronary artery stenosis treated with drug-eluting stents: results of the survey from the Italian Society of Invasive Cardiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Five-year follow-up after sirolimus-eluting stent implantation results of the SIRIUS (Sirolimus-Eluting Stent in De-Novo Native Coronary Lesions) Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Long-term effectiveness and safety of sirolimus stent implantation for coronary in-stent restenosis results of the TRUE (Tuscany Registry of sirolimus for unselected in-stent restenosis) registry at 4 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Twelve-month outcomes in patients with diabetes implanted with a zotarolimus-eluting stent: results from the E-Five Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Safety and effectiveness of the Endeavor zotarolimus-eluting stent in real-world clinical practice: 12-month data from the E-Five registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Two-year results of paclitaxel-eluting stents in patients with medically treated diabetes mellitus from the TAXUS ARRIVE program

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Drug-eluting or bare-metal stenting in patients with diabetes mellitus: results from the Massachusetts Data Analysis Center Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Clinical outcomes after unrestricted implantation of everolimus-eluting stents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Long-term outcomes after percutaneous coronary intervention in patients with and without diabetes mellitus in Western Denmark

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Outcomes in diabetic and nondiabetic patients treated with everolimus- or paclitaxel-eluting stents: results from the SPIRIT IV clinical trial (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Outcomes after sirolimus- and paclitaxel-eluting stent implantation in patients with insulin-treated diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Differences in restenosis rate with different drug-eluting stents in patients with and without diabetes mellitus: a report from the SCAAR (Swedish Angiography and Angioplasty Registry).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Clinical efficacy of drug-eluting stents in diabetic patients: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

The effect of drug-eluting stents on intermediate angiographic and clinical outcomes in diabetic patients: insights from randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Drug-eluting versus bare metal stents in patients with st-segment-elevation myocardial infarction: eight-month follow-up in the Drug Elution and Distal Protection in Acute Myocardial Infarction (DEDICATION) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Stent malapposition after sirolimus-eluting and bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: acute and 9-month intravascular ultrasound results of the MISSION! intervention study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Comparison of angioplasty with infusion of tirofiban or abciximab and with implantation of sirolimus-eluting or uncoated stents for acute myocardial infarction: the MULTISTRATEGY randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Paclitaxel-eluting versus uncoated stents in primary percutaneous coronary intervention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Single-center randomized evaluation of paclitaxel-eluting versus conventional stent in acute myocardial infarction (SELECTION).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Randomized trial of Sirolimus-Eluting Stent Versus Bare-Metal Stent in Acute Myocardial Infarction (SESAMI).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Tirofiban and sirolimus-eluting stent vs abciximab and bare-metal stent for acute myocardial infarction: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Sirolimus-eluting versus uncoated stents in acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Bivalirudin during primary PCI in acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Use of drug-eluting stents in acute myocardial infarction: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Mortality following placement of drug-eluting and bare-metal stents for ST-segment elevation acute myocardial infarction in the Global Registry of Acute Coronary Events

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Comparison of three-year clinical outcome of sirolimus- and paclitaxel-eluting stents versus bare metal stents in patients with ST-segment elevation myocardial infarction (from the RESEARCH and T-SEARCH Registries).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Long-term outcome after drug eluting stenting in patients with ST-segment elevation myocardial infarction: data from the REAL registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Drug-eluting or bare-metal stents for acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Treatment of drug-eluting stent restenosis with another drug-eluting stent: do not fail the second time!

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Repeated drug-eluting stent implantation for drug-eluting stent restenosis: the same or a different stent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Treatment of drug-eluting stent restenosis with the same versus different drug-eluting stent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Randomized trial of paclitaxel- versus sirolimus-eluting stents for treatment of coronary restenosis in sirolimus-eluting stents: the ISAR-DESIRE 2 (Intracoronary Stenting and Angiographic Results: Drug Eluting Stents for In-Stent Restenosis 2) stud

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Randomized study of the crush technique versus provisional side-branch stenting in true coronary bifurcations: the CACTUS (Coronary Bifurcations: Application of the Crushing Technique Using Sirolimus-Eluting Stents) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Randomized trial on routine vs. provisional T-stenting in the treatment of de novo coronary bifurcation lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Randomized trial of simple versus complex drug-eluting stenting for bifurcation lesions: the British Bifurcation Coronary Study: old, new, and evolving strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Randomized comparison of coronary bifurcation stenting with the crush versus the culotte technique using sirolimus eluting stents: the Nordic stent technique study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Randomized study on simple versus complex stenting of coronary artery bifurcation lesions: the Nordic bifurcation study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Long‐term risk of clinical events from stenting side branches of coronary bifurcation lesions with drug‐eluting and bare‐metal stents: An observational meta‐analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Long-term outcome of percutaneous catheter intervention for de novo coronary bifurcation lesions with drug-eluting stents or bare-metal stents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Simple versus complex stenting strategy for coronary artery bifurcation lesions in the drug-eluting stent era: a meta-analysis of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Randomized comparison of final kissing balloon dilatation versus no final kissing balloon dilatation in patients with coronary bifurcation lesions treated with main vessel stenting: the Nordic-Baltic Bifurcation Study III.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Sirolimus-eluting vs uncoated stents for prevention of restenosis in small coronary arteries: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Randomized trial of paclitaxel- and sirolimus-eluting stents in small coronary vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Long-term benefit-risk balance of drug-eluting vs. bare-metal stents in daily practice: does stent diameter matter? Three-year follow-up of BASKET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Twenty-four months clinical outcomes of sirolimus-eluting stents for the treatment of small coronary arteries: the long-term SES-SMART clinical study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Vessel size and outcome after coronary drug-eluting stent placement: results from a large cohort of patients treated with sirolimus- or paclitaxel-eluting stents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Clinical and angiographic follow-up of small vessel lesions treated with paclitaxel-eluting stents (from the TRUE Registry).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Two-year clinical outcome after coronary stenting of small vessels using 2.25-mm sirolimus- and paclitaxel-eluting stents: insight into the RESEARCH and T-SEARCH registries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Clinical and angiographic comparison of everolimus-eluting and paclitaxel-eluting stents in small coronary arteries: a post hoc analysis of the SPIRIT III randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

An everolimus-eluting stent versus a paclitaxel-eluting stent in small vessel coronary artery disease: a pooled analysis from the SPIRIT II and SPIRIT III trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Treatment of small coronary arteries with a paclitaxel-coated balloon catheter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Efficacy and safety of drug-eluting stents in chronic total coronary occlusion recanalization: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

The Stenting Coronary Arteries in Non-stress/benestent Disease (SCANDSTENT) trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Primary Stenting of Totally Occluded Native Coronary Arteries II (PRISON II): a randomized comparison of bare metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Three-year clinical outcomes after coronary stenting of chronic total occlusion using sirolimus-eluting stents: insights from the rapamycin-eluting stent evaluated at Rotterdam cardiology hospital-(RESEARCH) registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Clinical and angiographic outcomes with sirolimus-eluting stents in total coronary occlusions: the ACROSS/TOSCA-4 (Approaches to Chronic Occlusions With Sirolimus-Eluting Stents/Total Occlusion Study of Coronary Arteries-4) trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Comparison of sirolimus-eluting and bare metal stent for treatment of patients with total coronary occlusions: results of the GISSOC II-GISE multicentre randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

ACCF/SCAI/STS/AATS/AHA/ASNC 2009 Appropriateness Criteria for Coronary Revascularization: A Report of the American College of Cardiology Foundation Appropriateness Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Societ

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Experience with revascularization procedures does matter: low volume means worse outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Comparison of drug-eluting stents and bare-metal stents for the treatment of unprotected left main coronary artery disease in acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Long-term safety and effectiveness of unprotected left main coronary stenting with drug-eluting stents compared with bare-metal stents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

A collaborative systematic review and meta-analysis on 1278 patients undergoing percutaneous drug-eluting stenting for unprotected left main coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Drug-eluting versus bare-metal stents in unprotected left main coronary artery stenosis a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

A randomized comparison of paclitaxel-eluting stents versus bare-metal stents for treatment of unprotected left main coronary artery stenosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Two-year clinical outcome with drug-eluting stents versus bare-metal stents in a real-world registry of unprotected left main coronary artery stenosis from the Italian Society of Invasive Cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Early and long-term results of unprotected left main coronary artery stenting: the LE MANS (Left Main Coronary Artery Stenting) registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Stents versus coronary-artery bypass grafting for left main coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Comparison of long-term (4-year) outcomes of patients with unprotected left main coronary artery narrowing treated with drug-eluting stents versus coronary-artery bypass grafting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Comparison of coronary artery bypass surgery and percutaneous drug-eluting stent implantation for treatment of left main coronary artery stenosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Nonrandomized comparison of coronary artery bypass surgery and percutaneous coronary intervention for the treatment of unprotected left main coronary artery disease in octogenarians

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Comparison of percutaneous versus surgical revascularization of severe unprotected left main coronary stenosis in matched patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Three-year outcomes after sirolimus-eluting stent implantation for unprotected left main coronary artery disease: insights from the j-Cypher registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Impact of drug-eluting stent selection on long-term clinical outcomes in patients treated for unprotected left main coronary artery disease: the sirolimus vs paclitaxel drug-eluting stent for left main registry (SP-DELFT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Unprotected left main revascularization in patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

A meta-analysis of 3,773 patients treated with percutaneous coronary intervention or surgery for unprotected left main coronary artery stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Meta-analysis of studies comparing coronary artery bypass grafting with drug-eluting stenting in patients with diabetes mellitus and multivessel coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Increased late mortality with percutaneous stenting for unprotected left main coronary artery stenosis relative to coronary artery bypass grafting: a meta-analysis of observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Acute and late outcomes of unprotected left main stenting in comparison with surgical revascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Randomized trial of stents versus bypass surgery for left main coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Coronary stents: current status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Longest available clinical outcomes after drug-eluting stent implantation for unprotected left main coronary artery disease: the DELFT (Drug Eluting stent for LeFT main) Registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Long-term clinical outcomes of sirolimus- versus paclitaxel-eluting stents for patients with unprotected left main coronary artery disease: analysis of the MAIN-COMPARE (revascularization for unprotected left main coronary artery stenosis: compariso

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Paclitaxel- versus sirolimus-eluting stents for unprotected left main coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Unprotected left main stenting in the real world: two-year outcomes of the French left main taxus registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Long-term clinical outcome after fractional flow reserve-guided treatment in patients with angiographically equivocal left main coronary artery stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Impact of intravascular ultrasound guidance on long-term mortality in stenting for unprotected left main coronary artery stenosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Incidence, predictors, treatment, and long-term prognosis of patients with restenosis after drug-eluting stent implantation for unprotected left main coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Increased late mortality after sirolimus-eluting stents versus bare-metal stents in diseased saphenous vein grafts: results from the randomized DELAYED RRISC Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

A randomized controlled trial of a paclitaxel-eluting stent versus a similar bare-metal stent in saphenous vein graft lesions the SOS (Stenting of Saphenous Vein Grafts) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Drug-eluting stents compared with bare metal stents improve late outcome after saphenous vein graft but not after large native vessel interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Comparison by meta-analysis of drug-eluting stents and bare metal stents for saphenous vein graft intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Drug-eluting versus bare-metal stent for treatment of saphenous vein grafts: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Comparing the antiplatelet effect of clopidogrel hydrogensulfate and clopidogrel besylate: a crossover study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Increased active metabolite formation explains the greater platelet inhibition with prasugrel compared to high-dose clopidogrel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Prasugrel versus clopidogrel in patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a r

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Inhibition of platelet aggregation by AZD6140, a reversible oral P2Y12 receptor antagonist, compared with clopidogrel in patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD6140 with aspirin in patients with atherosclerosis: a double-blind comparison to clopidogrel with aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Ticagrelor versus clopidogrel in patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

The Registry of the German Competence NETwork on Atrial Fibrillation: patient characteristics and initial management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Coronary artery stenting and non-cardiac surgery--a prospective outcome study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Stent thrombosis in randomized clinical trials of drug-eluting stents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Late angiographic stent thrombosis (LAST) events with drug-eluting stents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Clinical end points in coronary stent trials: a case for standardized definitions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Thrombosis and drug-eluting stents: an objective appraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Incidence and clinical impact of coronary stent fracture after sirolimus-eluting stent implantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Stent fracture associated with drug-eluting stents: clinical characteristics and implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Late multiple stent fractures following deployment of sirolimus-eluting stents for diffuse right coronary artery stenosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Stent fracture, an incidental finding or a significant marker of clinical in-stent restenosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Sirolimus-eluting stents versus bare-metal stents in patients with ST-segment elevation myocardial infarction: 9-month angiographic and intravascular ultrasound results and 12-month clinical outcome results from the MISSION! Intervention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Randomized, non-inferiority trial of three limus agent-eluting stents with different polymer coatings: the Intracoronary Stenting and Angiographic Results: Test Efficacy of 3 Limus-Eluting Stents (ISAR-TEST-4) Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Comparison of everolimus-eluting and paclitaxel-eluting coronary stents in patients undergoing multilesion and multivessel intervention: the SPIRIT III (A Clinical Evaluation of the Investigational Device XIENCE V Everolimus Eluting Coronary Stent S

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Six-month results of the NEVO Res-Elution I (NEVO RES-I) trial: a randomized, multicenter comparison of the NEVO sirolimus-eluting coronary stent with the TAXUS Liberté paclitaxel-eluting stent in de novo native coronary artery lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Incidence and Management of Restenosis After Treatment of Unprotected Left Main Disease With Drug-Eluting Stents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Management of Antithrombotic Therapy in Atrial Fibrillation Patients Presenting with Acute Coronary Syndrome and/or Undergoing Percutaneous Coronary Intervention/ Stenting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

A Prospective, Randomized Evaluation of a Novel Everolimus-Eluting Coronary Stent

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Diabetic and Nondiabetic Patients With Left Main and/or 3-Vessel Coronary Artery Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6

Double-dose clopidogrel in patients undergoing PCI for ACS – Authors' reply

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12181-011-0375-6